AU2001239180A1 - Immunomodulatory effective compositions, methods for the production thereof and their use - Google Patents

Immunomodulatory effective compositions, methods for the production thereof and their use

Info

Publication number
AU2001239180A1
AU2001239180A1 AU2001239180A AU3918001A AU2001239180A1 AU 2001239180 A1 AU2001239180 A1 AU 2001239180A1 AU 2001239180 A AU2001239180 A AU 2001239180A AU 3918001 A AU3918001 A AU 3918001A AU 2001239180 A1 AU2001239180 A1 AU 2001239180A1
Authority
AU
Australia
Prior art keywords
production
methods
compositions
immunomodulatory effective
microbiological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239180A
Other languages
English (en)
Inventor
Angela Trenel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KLEINE AND STEUBE ENTOXIN GmbH
Original Assignee
KLEINE AND STEUBE ENTOXIN GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KLEINE AND STEUBE ENTOXIN GmbH filed Critical KLEINE AND STEUBE ENTOXIN GmbH
Publication of AU2001239180A1 publication Critical patent/AU2001239180A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2001239180A 2000-02-14 2001-02-12 Immunomodulatory effective compositions, methods for the production thereof and their use Abandoned AU2001239180A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10007771A DE10007771A1 (de) 2000-02-14 2000-02-14 Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE10007771 2000-02-14
PCT/DE2001/000578 WO2001058486A2 (de) 2000-02-14 2001-02-12 Immunmodulatorisch wirksame zusammensetzungen, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
AU2001239180A1 true AU2001239180A1 (en) 2001-08-20

Family

ID=7631660

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239180A Abandoned AU2001239180A1 (en) 2000-02-14 2001-02-12 Immunomodulatory effective compositions, methods for the production thereof and their use

Country Status (8)

Country Link
US (1) US20030003110A1 (da)
EP (1) EP1257293B1 (da)
AT (1) ATE304372T1 (da)
AU (1) AU2001239180A1 (da)
DE (2) DE10007771A1 (da)
DK (1) DK1257293T3 (da)
ES (1) ES2249418T3 (da)
WO (1) WO2001058486A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006120495A1 (fr) * 2005-05-13 2006-11-16 Advanced Scientific Developements Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
US20100291038A1 (en) * 2006-07-06 2010-11-18 Rajesh Shah Novel Medicinal Formulation for Inducing an Immune Response in Patients with Chronic and Recurring Infections
DE202007003266U1 (de) 2007-03-02 2008-07-17 Bufe, Albrecht, Prof. Dr. Med. Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen
EP1964570B1 (de) 2007-03-02 2012-11-21 Protectimmun GmbH Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen
US20120128597A1 (en) 2008-08-16 2012-05-24 Forschungszentrum Borstel Composition for prevention and treatment of allergic and/or inflammatory diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732763A (en) * 1978-10-17 1988-03-22 Stolle Research And Development Corporation Active/passive immunization of the internal female reproductive organs
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
US4756907A (en) * 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
DE3932100A1 (de) * 1989-09-26 1991-04-04 Malonga Makosi Jean Paul Dr Verfahren zur herstellung homoeopathischer arzneimittel in hochpotenzen
DE4236069A1 (de) * 1992-10-26 1994-04-28 Werner Dr Bergmann Arzneimittel, insbesondere für orale Einnahme
FR2699822A1 (fr) * 1992-12-24 1994-07-01 Pichot Eric Contribution à la prévention humaine du syndrome d'immuno-défiscience acquis (SIDA) induit par le virus d'immuno-défiscience humaine (VIH) par traitement homéo-iso-thérapique.
US5955077A (en) * 1993-07-02 1999-09-21 Statens Seruminstitut Tuberculosis vaccine
US5773570A (en) * 1994-05-20 1998-06-30 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
US6139850A (en) * 1994-12-21 2000-10-31 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
US5795582A (en) * 1996-02-07 1998-08-18 Novavax, Inc. Adjuvant properties of poly (amidoamine) dendrimers
US5733570A (en) * 1996-09-05 1998-03-31 Minnesota Mining And Manufacturing Company Absorbent dressing
US6440408B2 (en) * 1996-09-30 2002-08-27 University Of Arkansas Method of treatment
US6545130B2 (en) * 1997-06-04 2003-04-08 Albert Einstein College Of Medicine Of Yeshiva University Monoclonal antibodies to mycobacterium tuberculosis and a modified ELISA assay
WO1999012553A1 (en) * 1997-09-08 1999-03-18 Idec Pharmaceuticals Corporation Methods for producing human antibodies in scid mice using dendritic cells
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
EP1257293B1 (de) 2005-09-14
US20030003110A1 (en) 2003-01-02
ATE304372T1 (de) 2005-09-15
ES2249418T3 (es) 2006-04-01
WO2001058486A3 (de) 2002-04-25
EP1257293A2 (de) 2002-11-20
DE10007771A1 (de) 2001-08-23
DE50107423D1 (de) 2005-10-20
WO2001058486A2 (de) 2001-08-16
DK1257293T3 (da) 2006-01-30

Similar Documents

Publication Publication Date Title
DE60125797D1 (de) Impfstoffzusammesetzung
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
NO20061736L (no) Krystallform av epotilon B
HUP0301815A2 (hu) Fertżzż és egyéb betegségek kezelésére használható mono- és diszacharid alapú gyógyszerkészítmény és profilaktikus és terápiás kezelés
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
WO2002095030A3 (en) Modulation of cd200 receptors
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
HUP0002322A2 (hu) Multivalens vakcinakészítmény kevert hordozóval
MY142329A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
WO2004016750A3 (en) FcϜRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
WO2003055527A3 (en) Immunoconjugates useful for treatment of tumours
WO2004071529A3 (en) Uses of anti-insulin-like growth factor i receptor antibodies
EP2497478A3 (en) Oligosaccaride compositions and use thereof in the treatment of infection
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
PT1057828E (pt) Suspensoes de trovafloxacina para administracao oral
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
WO2002094745A3 (en) Non-peptidic cyclophilin binding compounds and their use
WO2003039453A3 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
HK1063601A1 (en) Compositions and methods for treating hyperimmune response in the eye
AU2001239180A1 (en) Immunomodulatory effective compositions, methods for the production thereof and their use
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo